Mirae Asset Global Investments Co. Ltd. Lowers Stake in Doximity, Inc. (NASDAQ:DOCS)

Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 7.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 119,168 shares of the company’s stock after selling 9,350 shares during the period. Mirae Asset Global Investments Co. Ltd. owned approximately 0.06% of Doximity worth $3,341,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Quantbot Technologies LP lifted its stake in shares of Doximity by 177.8% in the 3rd quarter. Quantbot Technologies LP now owns 136,782 shares of the company’s stock worth $2,903,000 after acquiring an additional 87,546 shares during the period. Vanguard Group Inc. lifted its stake in shares of Doximity by 5.9% in the 3rd quarter. Vanguard Group Inc. now owns 11,038,475 shares of the company’s stock worth $234,236,000 after acquiring an additional 616,157 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Doximity by 10.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock worth $14,834,000 after acquiring an additional 67,363 shares during the period. Fort Washington Investment Advisors Inc. OH acquired a new stake in shares of Doximity in the 4th quarter worth $6,518,000. Finally, Polen Capital Management LLC lifted its stake in shares of Doximity by 11.6% in the 3rd quarter. Polen Capital Management LLC now owns 215,037 shares of the company’s stock worth $4,563,000 after acquiring an additional 22,377 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00. Following the transaction, the director now owns 10,258 shares of the company’s stock, valued at approximately $276,658.26. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 39.40% of the stock is owned by company insiders.

Doximity Stock Up 0.5 %

Shares of NASDAQ:DOCS opened at $25.18 on Thursday. The company has a market capitalization of $4.70 billion, a P/E ratio of 38.15, a P/E/G ratio of 3.20 and a beta of 1.17. Doximity, Inc. has a 52-week low of $19.71 and a 52-week high of $37.10. The stock’s fifty day simple moving average is $27.68 and its 200-day simple moving average is $26.08.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.06. The firm had revenue of $135.28 million during the quarter, compared to analysts’ expectations of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. On average, sell-side analysts anticipate that Doximity, Inc. will post 0.72 earnings per share for the current year.

Analyst Ratings Changes

DOCS has been the subject of several recent analyst reports. Evercore ISI restated an “in-line” rating and issued a $30.00 target price on shares of Doximity in a research note on Tuesday, April 2nd. Wells Fargo & Company raised their price objective on shares of Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a research note on Friday, February 9th. Bank of America raised their price objective on shares of Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research note on Tuesday, January 23rd. JPMorgan Chase & Co. raised their price objective on shares of Doximity from $22.00 to $25.00 and gave the company an “underweight” rating in a research note on Friday, March 15th. Finally, SVB Leerink began coverage on shares of Doximity in a research note on Monday, February 26th. They issued a “market perform” rating and a $32.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $28.82.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.